[go: up one dir, main page]

DK0973413T3 - Food formulations containing lacto-N-neotetraose - Google Patents

Food formulations containing lacto-N-neotetraose

Info

Publication number
DK0973413T3
DK0973413T3 DK98913279T DK98913279T DK0973413T3 DK 0973413 T3 DK0973413 T3 DK 0973413T3 DK 98913279 T DK98913279 T DK 98913279T DK 98913279 T DK98913279 T DK 98913279T DK 0973413 T3 DK0973413 T3 DK 0973413T3
Authority
DK
Denmark
Prior art keywords
neotetraose
formulations containing
food formulations
lacto
containing lacto
Prior art date
Application number
DK98913279T
Other languages
Danish (da)
Other versions
DK0973413T4 (en
Inventor
Pedro A Prieto
Terry A Kroening
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0973413(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0973413T3 publication Critical patent/DK0973413T3/en
Publication of DK0973413T4 publication Critical patent/DK0973413T4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided.
DK98913279.0T 1997-03-31 1998-03-30 Nutritional compositions containing lacto-N-neotetraose DK0973413T4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/829,220 US5906982A (en) 1997-03-31 1997-03-31 Nutritional formulations containing Lacto-N-neoTetraose
PCT/US1998/006217 WO1998043495A1 (en) 1997-03-31 1998-03-30 Nutritional formulations containing lacto-n-neotetraose

Publications (2)

Publication Number Publication Date
DK0973413T3 true DK0973413T3 (en) 2004-11-29
DK0973413T4 DK0973413T4 (en) 2012-02-27

Family

ID=25253891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98913279.0T DK0973413T4 (en) 1997-03-31 1998-03-30 Nutritional compositions containing lacto-N-neotetraose

Country Status (11)

Country Link
US (2) US5906982A (en)
EP (1) EP0973413B2 (en)
JP (1) JP4148535B2 (en)
AT (1) ATE271788T1 (en)
CA (1) CA2285066C (en)
DE (1) DE69825260T3 (en)
DK (1) DK0973413T4 (en)
ES (1) ES2229486T5 (en)
NO (1) NO315254B1 (en)
PT (1) PT973413E (en)
WO (1) WO1998043495A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6375994B1 (en) * 1999-08-20 2002-04-23 Sun Ten Laboratories, Inc. Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
ATE305309T1 (en) * 2002-02-04 2005-10-15 Kyowa Hakko Kogyo Kk PHARMACEUTICAL AND FOOD COMPOSITIONS CONTAINING A DI- OR OLIGOSACCHARIDE THAT INCREASE INSULIN RELEASE
US20040047866A1 (en) * 2002-09-09 2004-03-11 President And Fellows Of Harvard College Immunomodulatory methods using carbohydrate antigens
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
DE102004040452A1 (en) * 2004-08-20 2006-02-23 N.V. Nutricia peptide mixture
EP1629850B2 (en) 2004-08-24 2013-05-22 N.V. Nutricia Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides
CA2603517A1 (en) * 2005-04-08 2006-11-02 Snow Brand Milk Products Co., Ltd. Iron composition containing milk protein
US8197872B2 (en) * 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
AU2008324105B2 (en) * 2007-11-08 2014-01-30 Société des Produits Nestlé S.A. Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2010098822A1 (en) 2009-02-24 2010-09-02 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP3202406A1 (en) * 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
WO2012092082A1 (en) * 2010-12-30 2012-07-05 Abbott Laboratories Reduced buffering capacity of a low calorie infant formula
EP2658402A1 (en) * 2010-12-31 2013-11-06 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
ES2708924T3 (en) 2010-12-31 2019-04-12 Abbott Lab Procedures for the use of oligosaccharides in human milk to improve respiratory health of the respiratory tract
NZ612455A (en) 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
WO2012092159A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CN110051676A (en) 2010-12-31 2019-07-26 雅培制药有限公司 For adjusting the human milk oligosaccharides of inflammation
BR112013016587A2 (en) 2010-12-31 2016-09-27 Abbott Lab nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
EP3510873A1 (en) 2010-12-31 2019-07-17 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
BR112014001472A2 (en) 2011-07-22 2017-02-21 Abbott Lab galactooligosaccharides to prevent injury and / or promote healing of the gastrointestinal tract
BR112014004772A2 (en) 2011-08-29 2017-03-21 Abbott Lab human milk oligosaccharides to prevent damage and / or promote healing of the gastrointestinal tract
MX354727B (en) * 2011-10-18 2018-03-16 Nestec Sa Composition for use in the promotion of magnesium absorption and/or magnesium retention.
EP2842560A4 (en) * 2012-04-23 2015-12-02 Univ Kyoto COMPOSITION FOR PROMOTING BIFIDOBACTERIUM GROWTH
CA2894897C (en) * 2012-12-20 2018-09-18 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) * 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
CN115350200A (en) 2014-12-08 2022-11-18 格礼卡姆股份公司 Synthetic compositions for the treatment of metabolic disorders
US10709721B2 (en) 2015-03-05 2020-07-14 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
MX379149B (en) 2015-08-04 2025-03-10 Soc Des Produits Nestle S A Star Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
EP3471562A4 (en) * 2016-06-15 2020-07-29 Glycom A/S SYNTHETIC COMPOSITIONS WITH MOTHER MILK OLIGOSACCHARIDES FOR THE PREVENTION AND TREATMENT OF DISEASES
AU2017307455B2 (en) 2016-08-04 2023-07-06 Société des Produits Nestlé S.A. Nutritional compositions with 2FL and LNnT for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis
WO2024024906A1 (en) * 2022-07-29 2024-02-01 森永乳業株式会社 Composition for promoting utilization of oligosaccharide in bifidobacterium breve
WO2025083289A1 (en) 2023-10-19 2025-04-24 N.V. Nutricia Mixture of human milk oligosaccharides
WO2025083288A1 (en) 2023-10-19 2025-04-24 N.V. Nutricia Mixture of human milk oligosaccharides
CN120859173A (en) * 2025-09-28 2025-10-31 内蒙古乳业技术研究院有限责任公司 Breast milk oligosaccharide capable of improving bioavailability of mineral zinc and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE518409A (en) *
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE462134B (en) * 1987-10-22 1990-05-14 Biocarb Ab FOOD CONTAINING LACTO-N-TETRAOS AND PROCEDURES FOR ITS PREPARATION
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
EP0481038B1 (en) * 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
AU692841B2 (en) * 1994-03-09 1998-06-18 Abbott Laboratories Transgenic animals producing oligosaccharides and glycoconjugates
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose

Also Published As

Publication number Publication date
ES2229486T3 (en) 2005-04-16
NO315254B1 (en) 2003-08-11
DK0973413T4 (en) 2012-02-27
PT973413E (en) 2004-11-30
JP4148535B2 (en) 2008-09-10
DE69825260T2 (en) 2005-08-04
DE69825260D1 (en) 2004-09-02
EP0973413B2 (en) 2011-11-09
NO994722D0 (en) 1999-09-28
ES2229486T5 (en) 2012-01-10
CA2285066A1 (en) 1998-10-08
US6083934A (en) 2000-07-04
ATE271788T1 (en) 2004-08-15
CA2285066C (en) 2010-06-08
DE69825260T3 (en) 2012-04-26
EP0973413B1 (en) 2004-07-28
NO994722L (en) 1999-09-28
EP0973413A1 (en) 2000-01-26
US5906982A (en) 1999-05-25
JP2001517950A (en) 2001-10-09
WO1998043495A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
DK0973413T3 (en) Food formulations containing lacto-N-neotetraose
GB0330009D0 (en) Probiotic tablet formulations
AU2003212265A1 (en) Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
GR3024836T3 (en) Fatty acid based compositions for the control of established plant infections
KR950702966A (en) Benzo-fused lactams promote release of growth hormone
GEP20032938B (en) Acaricide
ATE126972T1 (en) FORMULATION FOR TREATING SILAGE.
ES2191066T3 (en) ENANTIOSELECTIVA PREPARATION OF PHARMACEUTICALLY ACTIVE SULFOXIDES BY BIOOXIDATION.
MX9708793A (en) Bacterial treatment for silage.
YU66295A (en) ANIMAL SUPPLEMENT AND ITS APPLICATION FOR MYCOTOXIN DEactivation AND ANIMAL PREPARATION PROCEDURE
CA2085258A1 (en) Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
MY101600A (en) An agricultural composition with reduced toxicity to fishes and shellfishes.
NO952575L (en) Liquid vanillin mixture, its preparation and use
NZ514054A (en) Pet food product with coconut endosperm fibre
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
CA2100774A1 (en) Feed additive and method
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
BR0012973B1 (en) Use of lactic acid bacteria belonging to the genus Bifidobacterium, and food or pharmaceutical composition.
JPS5440178A (en) Growth promoting agent for domestic animals
NZ223430A (en) A composition comprising an enzyme(s) having n-acetyl-muramidase activity
EA200200704A1 (en) IMMEDIATE MICROORGANISMS FOR THE TREATMENT OF INFECTION
ES2097706A1 (en) Cockroach repellent composition.
GEP20002242B (en) Herbicidal 3,5-Difluoropyridines
WO1997010801A3 (en) Nisin compositions to prevent the promotion of tooth decay by suppressing formation of acid from foods by oral bacteria
AU3903701A (en) Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase